Almi Invest is investing SEK 2.5 million in the biotechnology company Kromnigon, which is developing new methods for multi-staining of cells and tissues, which is of great importance in research and cancer treatment. The West Coast Business Angels also participate in the issue of a total of just over SEK 5 million. The money will be used for product development, sales and to establish the organization. Antibody-based staining of cells and tissues (immunostaining) is a common method in research, drug development and healthcare, and an important piece of the puzzle in the development of immunotherapy,...

In March 2021, Kromnigon joined the AstraZeneca’s BioVentureHub. Immunofluorescence microscopy is an imaging technique that can help visualise many proteins or cells in a single tissue section. The rapid expansion of immunofluorescence imaging within drug and diagnostics development is driven by the need to more accurately map immune cell influx into diseased tissues, such as tumours. This makes it easier to screen patients to determine personalized treatment therapies and to evaluate clinical responses. Henric Olsson, Head of Target Science, Research and Early Development, Respiratory...